<DOC>
	<DOC>NCT01738165</DOC>
	<brief_summary>The purpose of this pilot study is to collect data on the safety and effectiveness of the KineSpring System in patients with primarily unicompartmental medial knee osteoarthritis.</brief_summary>
	<brief_title>Study of the KineSpringÂ® System to Evaluate Symptom Relief in Patients With Medial Knee Osteoarthritis</brief_title>
	<detailed_description>The KineSpring System is indicated to treat symptoms of pain and loss of knee function in patients with a diagnosis of osteoarthritis or post-traumatic osteoarthritis in the medial compartment of the knee. The KineSpring System is indicated for patients with osteoarthritis of severity that does not require knee joint replacement.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Inclusion Criteria (Significant criteria only. Others also apply): Patients with symptoms of knee pain and loss of knee function. Patients with a diagnosis of osteoarthritis or posttraumatic osteoarthritis in the medial compartment of the knee. Radiographic confirmation of mild to moderate medial compartment knee OA Exclusion Criteria (Significant criteria only. Others also apply): Patients that that require knee joint replacement. Symptomatic OA in lateral compartment or patellofemoral compartment. Known sensitivity to metals including cobalt, chromium, iron, or nickel Rheumatoid arthritis, other forms of inflammatory joint disease</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prospective</keyword>
	<keyword>Multi-Center</keyword>
	<keyword>Pilot Study</keyword>
	<keyword>Single Arm</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
</DOC>